Literature DB >> 4829933

Effect of ethidium bromide on elimination of exfoliative toxin and bacteriocin production in Staphylococcus aureus.

R Warren, M Rogolsky, B B Wiley, L A Glasgow.   

Abstract

The scalded skin syndrome has been associated with phage group II staphylococci. The clinical manifestations of scalded skin syndrome, Ritter's disease, scarlatiniform erythema, and localized bullous impetigo, are due to the production of an extracellular protein, designated exfoliative toxin. Phage group II staphylococci can also produce an extracellular protein, bacteriocin, which is bacteriocidal for specific gram-positive microorganisms. Strain UT 0007 produces both bacteriocin and exfoliative toxin which appear to be products of extrachromosomal genes. These genes are jointly eliminated from strain UT 0007 after growth in either ethidium bromide or at high temperatures.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4829933      PMCID: PMC246847          DOI: 10.1128/jb.118.3.980-985.1974

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  17 in total

1.  Single-disk antibiotic-sensitivity testing of staphylococci; an analysis of technique and results.

Authors:  A W BAUER; D M PERRY; W M KIRBY
Journal:  AMA Arch Intern Med       Date:  1959-08

2.  Nature of the genetic determinant controlling exfoliative toxin production in Staphylococcus aureus.

Authors:  M Rogolsky; R Warren; B B Wiley; H T Nakamura; L A Glasgow
Journal:  J Bacteriol       Date:  1974-01       Impact factor: 3.490

3.  Purification of exfoliatin produced by Staphylococcus aureus of bacteriophage group 2 and its physicochemical properties.

Authors:  I Kondo; S Sakurai; Y Sarai
Journal:  Infect Immun       Date:  1973-08       Impact factor: 3.441

4.  The scalded-skin syndrome: relation to phage-group II staphylococci.

Authors:  A S Dajani
Journal:  J Infect Dis       Date:  1972-05       Impact factor: 5.226

5.  Staphylococcal scalded skin syndrome: the expanded clinical syndrome.

Authors:  M E Melish; L A Glasgow
Journal:  J Pediatr       Date:  1971-06       Impact factor: 4.406

6.  The staphylococcal scalded-skin syndrome.

Authors:  M E Melish; L A Glasgow
Journal:  N Engl J Med       Date:  1970-05-14       Impact factor: 91.245

7.  Product of Staphylococcus aureus responsible for the scalded-skin syndrome.

Authors:  F A Kapral; M M Miller
Journal:  Infect Immun       Date:  1971-11       Impact factor: 3.441

8.  Characteristics of group A streptococcal bacteriophages.

Authors:  P L Friend; M D Slade
Journal:  J Bacteriol       Date:  1966-07       Impact factor: 3.490

9.  Effects of ethidium bromide on growth and on loss of the penicillinase plasmid of Staphylococcus aureus.

Authors:  S J Rubin; E D Rosenblum
Journal:  J Bacteriol       Date:  1971-12       Impact factor: 3.490

10.  Characterization and extrachromosomal control of bacteriocin production in Staphylococcus aureus.

Authors:  A M Jetten; G D Vogels
Journal:  Antimicrob Agents Chemother       Date:  1973-07       Impact factor: 5.191

View more
  18 in total

Review 1.  Colicinogeny and related phenomena.

Authors:  K G Hardy
Journal:  Bacteriol Rev       Date:  1975-12

2.  Phage group II staphylococcal strains with chromosomal and extrachromosomal genes for exfoliative toxin production.

Authors:  M Rogolsky; B B Wiley; L A Glasgow
Journal:  Infect Immun       Date:  1976-01       Impact factor: 3.441

3.  Isolation of extrachromosomal deoxyribonucleic acid for exfoliative toxin production from phage group II Staphylococcus aureus.

Authors:  R Warren; M Rogolsky; B B Wiley; L A Glasgow
Journal:  J Bacteriol       Date:  1975-04       Impact factor: 3.490

4.  Chromosomal synthesis of staphylococcal exfoliative toxin.

Authors:  M Keyhani; M Rogolsky; B B Wiley; L A Glasgow
Journal:  Infect Immun       Date:  1975-07       Impact factor: 3.441

Review 5.  Nonenteric toxins of Staphylococcus aureus.

Authors:  M Rogolsky
Journal:  Microbiol Rev       Date:  1979-09

6.  Production and properties of a staphylococcin genetically controlled by the staphylococcal plasmid for exfoliative toxin synthesis.

Authors:  M Rogolsky; B B Wiley
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

7.  Sequence of the exfoliative toxin B gene of Staphylococcus aureus.

Authors:  M P Jackson; J J Iandolo
Journal:  J Bacteriol       Date:  1986-08       Impact factor: 3.490

Review 8.  Bacteriocins of gram-positive bacteria.

Authors:  J R Tagg; A S Dajani; L W Wannamaker
Journal:  Bacteriol Rev       Date:  1976-09

9.  Exfoliative toxin plasmids of bacteriophage group 2 Staphylococcus aureus: sequence homology.

Authors:  R L Warren
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

10.  Production of megacins C and Cx: presumptive evidence extrachromosomal control.

Authors:  H D Donoghue
Journal:  Antimicrob Agents Chemother       Date:  1977-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.